• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

源自曼氏血吸虫侵袭期的T细胞肽作为潜在的血吸虫病疫苗

T Cell Peptides Derived from Invasive Stages of as Potential Schistosomiasis Vaccine.

作者信息

López-Abán Julio, Vicente Belén, Kabbas-Piñango Elías, Hernández-Goenaga Juan, Sánchez-Montejo Javier, Aguiriano María, Del Olmo Esther, Vanegas Magnolia, Patarroyo Manuel Alfonso, Muro Antonio

机构信息

Infectious and Tropical Diseases Group (e-INTRO), IBSAL-CIETUS (Biomedical Research Institute of Salamanca-Research Centre for Tropical Diseases at the University of Salamanca), Faculty of Pharmacy, University of Salamanca, Ldo Méndez Nieto s/n, 37007 Salamanca, Spain.

Department of Pharmaceutical Chemistry, IBSAL-CIETUS, Faculty of Pharmacy, University of Salamanca, Ldo Méndez Nieto s/n, 37007 Salamanca, Spain.

出版信息

J Clin Med. 2021 Jan 24;10(3):445. doi: 10.3390/jcm10030445.

DOI:10.3390/jcm10030445
PMID:33498845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7865475/
Abstract

Schistosomiasis is a parasitic disease that affects 143 million people in endemic countries. This work analyzed overexpressed sequences from the cercaria phase to the early schistosomulum phase using bioinformatics tools to predict host interaction and selected proteins for predicting T cell epitopes. The final peptides were chemically synthesized, and their toxicity was evaluated in vitro. Peptides were formulated in the Adjuvant Adaptation (ADAD) vaccination system and injected into BALB/c mice that were challenged with cercariae to assess protection and immunogenicity. A total of 39 highly expressed proteins were identified as being of potential interest. Three T cell peptides predicted to bind MHC mouse and human class II were synthesized and formulated for vaccination. SmGSP and SmIKE reduced the number of eggs trapped in the liver by more than 50% in challenged BALB/c mice. The liver of mice vaccinated with either SmGSP or SmTNP had a significantly reduced affected liver surface. Transcriptome-based T cell peptides elicit partial protection and could be candidates for a multiantigen vaccine.

摘要

血吸虫病是一种寄生虫病,在流行国家影响着1.43亿人。这项工作使用生物信息学工具分析了从尾蚴阶段到早期童虫阶段的过表达序列,以预测宿主相互作用,并选择用于预测T细胞表位的蛋白质。最终的肽段通过化学合成,并在体外评估其毒性。肽段被配制在佐剂适应性(ADAD)疫苗接种系统中,并注射到用尾蚴攻击的BALB/c小鼠体内,以评估其保护性和免疫原性。总共鉴定出39种高表达的潜在感兴趣蛋白质。合成并配制了三种预测可与MHC小鼠和人类II类结合的T细胞肽用于疫苗接种。在受到攻击的BALB/c小鼠中,SmGSP和SmIKE使肝脏中捕获的虫卵数量减少了50%以上。接种SmGSP或SmTNP的小鼠肝脏受影响的表面明显减少。基于转录组的T细胞肽可引发部分保护作用,可能成为多抗原疫苗的候选物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f0/7865475/d73aaf7c8d60/jcm-10-00445-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f0/7865475/2883a63370ec/jcm-10-00445-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f0/7865475/6232c848a091/jcm-10-00445-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f0/7865475/83cfa49864ce/jcm-10-00445-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f0/7865475/d73aaf7c8d60/jcm-10-00445-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f0/7865475/2883a63370ec/jcm-10-00445-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f0/7865475/6232c848a091/jcm-10-00445-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f0/7865475/83cfa49864ce/jcm-10-00445-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f0/7865475/d73aaf7c8d60/jcm-10-00445-g004.jpg

相似文献

1
T Cell Peptides Derived from Invasive Stages of as Potential Schistosomiasis Vaccine.源自曼氏血吸虫侵袭期的T细胞肽作为潜在的血吸虫病疫苗
J Clin Med. 2021 Jan 24;10(3):445. doi: 10.3390/jcm10030445.
2
Peptides Derived of Kunitz-Type Serine Protease Inhibitor as Potential Vaccine Against Experimental Schistosomiasis.Kunitz 型丝氨酸蛋白酶抑制剂衍生肽作为抗实验性血吸虫病疫苗的潜在应用。
Front Immunol. 2019 Nov 1;10:2498. doi: 10.3389/fimmu.2019.02498. eCollection 2019.
3
Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems.使用源自肝片吸虫的脂肪酸结合蛋白通过不同递送系统预防曼氏血吸虫感染。
Parasit Vectors. 2016 Apr 18;9:216. doi: 10.1186/s13071-016-1500-y.
4
The combination of the aliphatic diamine AA0029 in ADAD vaccination system with a recombinant fatty acid binding protein could be a good alternative for the animal schistosomiasis control.在ADAD疫苗接种系统中,脂肪族二胺AA0029与重组脂肪酸结合蛋白的组合可能是控制动物血吸虫病的一种良好替代方法。
Exp Parasitol. 2015 Jul;154:134-42. doi: 10.1016/j.exppara.2015.04.022. Epub 2015 Apr 30.
5
KI-1 or Its C-Terminal Fragment Induces Partial Protection Against Infection in Mice.KI-1 或其 C 末端片段可诱导小鼠部分抗感染。
Front Immunol. 2018 Jul 30;9:1762. doi: 10.3389/fimmu.2018.01762. eCollection 2018.
6
Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.曼氏血吸虫体外肺期幼虫排泄分泌抗原作为抗血吸虫病疫苗候选物
Vaccine. 2009 Jan 29;27(5):666-73. doi: 10.1016/j.vaccine.2008.11.039. Epub 2008 Dec 3.
7
Human T cell epitope mapping of the Schistosoma mansoni 14-kDa fatty acid-binding protein using cells from patients living in areas endemic for schistosomiasis.利用血吸虫病流行地区患者的细胞对曼氏血吸虫14 kDa脂肪酸结合蛋白进行人T细胞表位定位
Microbes Infect. 2005 Feb;7(2):204-12. doi: 10.1016/j.micinf.2004.10.012. Epub 2005 Jan 19.
8
Identification of Th1 epitopes within molecules from the lung-stage schistosomulum of Schistosoma japonicum by combining prediction analysis of the transcriptome with experimental validation.通过结合转录组预测分析与实验验证来鉴定日本血吸虫肺期童虫分子中的Th1表位
Parasitol Int. 2012 Dec;61(4):586-93. doi: 10.1016/j.parint.2012.05.010. Epub 2012 May 19.
9
The Schistosoma mansoni cyclophilin A epitope 107-121 induces a protective immune response against schistosomiasis.曼氏血吸虫环孢素 A 表位 107-121 诱导针对血吸虫病的保护性免疫反应。
Mol Immunol. 2019 Jul;111:172-181. doi: 10.1016/j.molimm.2019.04.021. Epub 2019 May 4.
10
The use of a conformational cathepsin D-derived epitope for vaccine development against Schistosoma mansoni.使用一种构象性组织蛋白酶D衍生表位开发抗曼氏血吸虫疫苗。
Bioorg Med Chem. 2015 Mar 15;23(6):1307-12. doi: 10.1016/j.bmc.2015.01.033. Epub 2015 Jan 30.

引用本文的文献

1
Circulating cell-free DNA as a biomarker for diagnosis of Schistosomiasis japonica.循环游离 DNA 作为日本血吸虫病诊断的生物标志物。
Parasit Vectors. 2024 Mar 6;17(1):114. doi: 10.1186/s13071-024-06203-x.

本文引用的文献

1
Arachidonic Acid Is a Safe and Efficacious Schistosomicide, and an Endoschistosomicide in Natural and Experimental Infections, and Cysteine Peptidase Vaccinated Hosts.花生四烯酸是一种安全有效的杀血吸虫药物,也是天然和实验性感染以及半胱氨酸蛋白酶疫苗接种宿主的内杀血吸虫药物。
Front Immunol. 2020 Nov 17;11:609994. doi: 10.3389/fimmu.2020.609994. eCollection 2020.
2
Recent Progress in the Development of Liver Fluke and Blood Fluke Vaccines.肝吸虫和血吸虫疫苗研发的最新进展
Vaccines (Basel). 2020 Sep 22;8(3):553. doi: 10.3390/vaccines8030553.
3
Current status and future prospects of protein vaccine candidates against infection.
抗感染蛋白候选疫苗的现状与未来前景。
Parasite Epidemiol Control. 2020 Aug 20;11:e00176. doi: 10.1016/j.parepi.2020.e00176. eCollection 2020 Nov.
4
Pathogen-host interaction mediated by vesicle-based secretion in schistosomes.血吸虫中基于囊泡分泌介导的病原体-宿主相互作用。
Protoplasma. 2020 Sep;257(5):1277-1287. doi: 10.1007/s00709-020-01515-y. Epub 2020 May 27.
5
Vaccination against the digestive enzyme Cathepsin B using a YS1646 Salmonella enterica Typhimurium vector provides almost complete protection against Schistosoma mansoni challenge in a mouse model.用 YS1646 沙门氏菌 Typhimurium 载体对消化酶组织蛋白酶 B 进行免疫接种,可在小鼠模型中几乎完全抵抗曼氏血吸虫的攻击。
PLoS Negl Trop Dis. 2019 Dec 2;13(12):e0007490. doi: 10.1371/journal.pntd.0007490. eCollection 2019 Dec.
6
Peptides Derived of Kunitz-Type Serine Protease Inhibitor as Potential Vaccine Against Experimental Schistosomiasis.Kunitz 型丝氨酸蛋白酶抑制剂衍生肽作为抗实验性血吸虫病疫苗的潜在应用。
Front Immunol. 2019 Nov 1;10:2498. doi: 10.3389/fimmu.2019.02498. eCollection 2019.
7
Safety and efficacy of the rSh28GST urinary schistosomiasis vaccine: A phase 3 randomized, controlled trial in Senegalese children.rSh28GST 尿血吸虫病疫苗的安全性和有效性:塞内加尔儿童的 3 期随机对照试验。
PLoS Negl Trop Dis. 2018 Dec 7;12(12):e0006968. doi: 10.1371/journal.pntd.0006968. eCollection 2018 Dec.
8
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家层面 195 个国家和地区 1990 年至 2017 年 354 种疾病和伤害导致的发病率、患病率和伤残损失寿命年:基于 2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1789-1858. doi: 10.1016/S0140-6736(18)32279-7. Epub 2018 Nov 8.
9
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家按年龄、性别和死因分类的死亡率,195 个国家和地区,1980-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1736-1788. doi: 10.1016/S0140-6736(18)32203-7. Epub 2018 Nov 8.
10
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、地区和国家残疾调整生命年(DALYs)359 种疾病和伤害以及 195 个国家和地区 1990-2017 年的健康期望寿命(HALE):2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1859-1922. doi: 10.1016/S0140-6736(18)32335-3.